Deletion and duplication sequences induced in CHO cells by teniposide (VM-26), a topoisomerase II targeting drug, can be explained by the processing of DNA nicks produced by the drug-topoisomerase interaction

This publication has 16 references indexed in Scilit:

• A proflavin-induced frameshift hotspot in the thymidylate synthase gene of bacteriophage T4
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
• Small Deletion and Insertion Mutations Induced by the Topoisomerase II Inhibitor Teniposide in CHO Cells and Comparison with Sites of Drug-stimulated DNA Cleavage in Vitro
  Journal of Molecular Biology, 1993
• Incomplete reversion of double stranded DNA cleavage mediated byDrosophilatopoisomerase II: formation of single stranded DNA cleavage complex in the presence of an anti-tumor drug VM26
  Nucleic Acids Research, 1992
• Chromosome recombination and defective genome segregation induced in Chinese hamster cells by the topoisomerase II inhibitor VM-26
  Chromosoma, 1991
• Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) in vivo and in vitro
  Mutagenesis, 1990
• Mutagenicity and clastogenicity of proflavin in L5178Y/TK+/−−3.7.2.C cells
  Mutation Research/Genetic Toxicology, 1988
• Mutagenicity of topoisomerase-active agents in bacteriophage T4
  Teratogenesis, Carcinogenesis, and Mutagenesis, 1988
• Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK+/−−3.7.2C mouse lymphoma cells
  Mutation Research/Genetic Toxicology, 1987
• 9-Aminoacridine mutagenesis of bacteriophage T4 intracellular DNA
  Molecular Genetics and Genomics, 1975
• Effects of 9-aminoacridine on bacteriophage T4 deoxyribonucleic acid synthesis
  Journal of Molecular Biology, 1970